Close
Nordic 9Nordic 9

Apollo Health Ventures (investor - Venture Capital)

Germany apollo.vc
See something wrong or missing? Let us know
Offices:Berlin, Cambridge

Apollo Health Ventures is a venture capital firm from Berlin, investing in seed and early stage biotechnology companies.

Average round investment:22.26M USD
Average number per year:1.8
Distribution: 2025 (2)2024 (2)2022 (2)2021 (1)
Portfolio companies: United Kingdom Scripta TherapeuticsSwitzerland Haya TherapeuticsGermany Refoxy Pharma See the entire list
Mostly invests in: Germany Germany (3) Health services (7)
See the entire list

Showing 3 of 7 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Apollo Health Ventures

Name Criteria
Belgium VIB
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Germany Evonik Venture Capital GmbH
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States +ND Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Switzerland Roche Venture Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Belgium European Investment Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
United Kingdom Isomer Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany, United Kingdom
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Germany Gründerfonds Ruhr
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
United States Illumina Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Northpond Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany, United Kingdom, Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Singapore Clay Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany, United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top